27 Sep 22
EINDHOVEN, the Netherlands, LAUSANNE, Switzerland & BOSTON, MA USA — September 27, 2022, 7:30 CET– ONWARD Medical N.V. (Euronext: ONWD), the medical technology company creating innovative therapies to restore movement, independence, and health in people with spinal cord injury, today announces its first half 2022 financial and operating results.
26 Sep 22
EINDHOVEN, the Netherlands, LAUSANNE, Switzerland, and BOSTON, MA USA—September 26, 2022—ONWARD Medical N.V. (Euronext: ONWD), the medical technology company creating innovative therapies to restore movement, independence, and health in people with spinal cord injury, today announced the appointment of Vivian Riefberg as a non-executive member of its Board of Directors.
21 Sep 22
EINDHOVEN, the Netherlands, LAUSANNE, Switzerland, and BOSTON, MA USA—September 21, 2022—ONWARD Medical N.V. (Euronext: ONWD), the medical technology company creating innovative therapies to restore movement, independence, and health in people with spinal cord injury, today announced it will publish the half year 2022 financial and operating results on Tuesday, September 27, 2022.
13 Sep 22

EINDHOVEN, the Netherlands, LAUSANNE, Switzerland, and BOSTON, USA—September 13, 2022--ONWARD Medical N.V. (Euronext: ONWD), the medical technology company creating innovative therapies to restore movement, independence, and health in people with spinal cord injury (SCI), today announced that the Up-LIFT pivotal study evaluating ARC-EX Therapy achieved its primary effectiveness

Upcoming Events

Recent Presentations